Corestemchemon Inc banner
C

Corestemchemon Inc
KOSDAQ:166480

Watchlist Manager
Corestemchemon Inc
KOSDAQ:166480
Watchlist
Price: 2 175 KRW -0.23%
Market Cap: ₩115B

Wall St Price Targets

Price Targets Summary
Corestemchemon Inc

There are no price targets for Corestemchemon Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Corestemchemon Inc Competitors:
Price Targets
RCR
RL Commercial REIT Inc
16% Upside
PTEN
Patterson-UTI Energy Inc
19% Upside
NNOX
Nano-X Imaging Ltd
427% Upside
SUPN
Supernus Pharmaceuticals Inc
37% Upside
ONDS
Ondas Holdings Inc
120% Upside

Revenue
Forecast

15% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 9 years is 0%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Corestemchemon Inc's stock price target?
Not Available

Corestemchemon Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Corestemchemon Inc?
Projected CAGR
0%

Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 9 years is 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett